Get the latest NAV of Tata India Pharma & Healthcare Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.
₹33.58
▲1.2%1D
NAV as on 12 May 2025
13.8%/per year
Since Inception
▲▼
2606 people have invested ₹ 1.3Cr in Tata India Pharma & Healthcare Fund Direct Growth in the last three months
Fund returns vs Benchmark returns vs Category Average returns as on (12-May-25)
The fund has outperformed the benchmark (Nifty 500) over 1Y, 3Y, but underperformed over 5Y.
Powered by IND quant engine
IND ranking is not available for this fund.
Calculate SIP and lumpsum returns based on historical performance
Total Investment
0
Profit
Total Corpus
0
See fund asset allocation details as on (15-Apr-25)
Fund Distribution
as on (15-Apr-25)
Equity 93.4%
Debt & Cash 6.6%
See fund sector allocation details as on (15-Apr-25)
Sector Allocation
Equity 93.4%
Debt & Cash 6.6%
Top 2 Sectors in March were Health, Basic Materials
Health
98%
Basic Materials
2%
Health
98%
Basic Materials
2%
as on (30-Apr-25)
Equity
Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.
Expense ratio | 0.67% |
Benchmark | Nifty Pharma TR INR |
AUM | ₹1223 Cr |
Inception Date | 28 December, 2015 |
Min Lumpsum/SIP | ₹5000/₹100 |
Exit Load | 0.2% |
Lock In | No Lock-in |
TurnOver | 28.44% |
STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
Risk | Very High Risk |
Tata India Pharma & Healthcare Fund Direct Growth is an equity fund. This fund was started on 28 December, 2015. The fund is managed by Meeta Shetty. The fund could potentially beat inflation in the long-run.
Tata India Pharma & Healthcare Fund Direct Growth has given a CAGR return of 13.80% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 18.47%, 25.03% and 23.68% respectively.
Tata India Pharma & Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Aurobindo Pharma Ltd, Apollo Hospitals Enterprise Ltd, Divi's Laboratories Ltd
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 100.00. Tata India Pharma & Healthcare Fund Direct Growth has no lock in period.
Fund Manager of Tata India Pharma & Healthcare Fund Direct Growth, since 9 March 2021
5Y CAGR
▲ 37.97
3Y CAGR
▲ 25.58
5Y CAGR
▲ 25.54
5Y CAGR
▲ 32.96
5Y CAGR
▲ 30.03
Tata India Pharma & Healthcare Fund
VS
Nippon India Pharma Fund Direct Growth
Tata India Pharma & Healthcare Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | 3.32% | 3.32% |
6 Month Returns | -2.41% | -2.41% |
1 Year Returns | 18.47% | 18.47% |
3 Years Returns | 95.47% | 25.03% |
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
Tata India Pharma & Healthcare Fund Direct Growth | 2.49 | 3.78 | 4.92 |
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
Tata India Pharma & Healthcare Fund Direct Growth | 1 | 0.95 | 0.91 |
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
Tata India Pharma & Healthcare Fund Direct Growth | 0.59 | 0.91 | 1.09 |
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
Tata India Pharma & Healthcare Fund Direct Growth | 20.6 | 16.72 | 16.11 |